A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies
Titel:
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies
Auteur:
Ribrag, Vincent Iglesias, Lara De Braud, Filippo Ma, Brigette Yokota, Tomoya Zander, Thomas Spreafico, Anna Subbiah, Vivek Illert, Anna L. Tan, Daniel Santoro, Armando Munster, Pamela N. Suehiro, Youko Wang, Yongsheng Ji, Dong-Mei Chen, Shuqi Beltz, Karen Suenaga, Naoko Ramkumar, Thiruvamoor Luo, Fangjun Lai, Clinton Wainberg, Zev A.